Understanding the dose-response relationship of allopurinol: predicting the optimal dosage. - Wikidata - wikimedia - TriplyDB

Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

http://www.wikidata.org/entity/Q37353448

about

The management of gout Review: Gout: A Roadmap to Approaches for Improving Global Outcomes Allopurinol: insights from studies of dose-response relationships.Editors' pick 2013.Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout Predicting allopurinol response in patients with gout Safety and efficacy of allopurinol in chronic kidney disease.Pharmacokinetics considerations for gout treatments.Current and future therapies for gout.Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat.Individualising the dose of allopurinol in patients with gout.How to prevent allopurinol hypersensitivity reactions?Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout

P2860

Q28069759-0D1A3E1E-22A5-4952-B0AF-7872D7C010D1 Q28076018-3898F13D-1FBB-4362-9FE5-B679B09EFC87 Q30240163-200B6A90-14DB-4D12-8577-D60548BF5C5D Q33582058-AC641A10-3EDB-4017-B794-F676F689687C Q34476295-6AB20FE3-BC6B-4505-81FE-B77EA4F0B8DD Q36802064-208B7F2A-8E92-4DA4-B8C3-3E73BBD0C267 Q38164653-B4AE1BF9-FAF7-4E59-AE97-2743E4596D98 Q38210284-C43428F8-D233-469D-97A8-058DB9490047 Q38660829-DA59F2EA-BEE2-42D7-8A8A-089514EE8ADA Q39278948-510B0106-5EB7-4E80-8086-774B980C7EFA Q48266996-2757C5A8-89EE-46DC-A30B-CD1A150E97F4 Q49616100-52A39322-6595-4CEF-970E-14AA22437AA6 Q50000842-EF555ADD-7A0C-4385-9481-AB6E4E104E2E Q57154626-3E3D14A8-C60D-471B-AF59-77FDBE039FA7

P2860

Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

http://www.wikidata.org/entity/Q37353448

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Understanding the dose-respons ...... predicting the optimal dosage.

@en

Understanding the dose-respons ...... predicting the optimal dosage.

@nl

type

label

Understanding the dose-respons ...... predicting the optimal dosage.

@en

Understanding the dose-respons ...... predicting the optimal dosage.

@nl

prefLabel

Understanding the dose-respons ...... predicting the optimal dosage.

@en

Understanding the dose-respons ...... predicting the optimal dosage.

@nl

P1433

Q37353448-8082E642-5912-415C-AD11-E54B91EE6C26

P1476

Q37353448-6C8B68CB-3E0B-4923-BB93-2AC17516854C

P2093

Q37353448-1AB74480-ED97-4D4A-8518-B341F99EE57A

Q37353448-54AAC7E0-645C-498A-81E5-8E50A8405503

Q37353448-78112E54-746F-4EA6-AC77-4BB572BA60CD

Q37353448-7CFAC334-F7ED-423D-A378-FAA2051AFEEB

Q37353448-AF5927D4-54C0-4A9E-A493-E4804C454DAA

Q37353448-C3DE93B5-A12B-4BC8-896F-0E2BD86338BE

Q37353448-D4D52263-7AE1-4977-8D5D-77741A02D4EA

P2860

Q37353448-0B6CA8C8-4F31-482A-A55E-F599DB2A78F2

Q37353448-21C6F2DF-2B47-4A66-B05E-E3EEBE6F243A

Q37353448-27F2078F-C849-473C-9862-E0EC32DE2BFE

Q37353448-56737E14-5634-42ED-A55F-09D846325064

Q37353448-58834F66-5C9C-4EC2-8782-B82AF92649C1

Q37353448-5C7C4DDE-1D00-4E61-9E44-A20654EADC5F

Q37353448-6F8617AC-1BE8-486A-94D0-3977EA435064

Q37353448-76DB2E92-595A-4F18-8B75-073EEA401584

Q37353448-80C62B69-E8B2-4156-9B5F-42B1BC83E084

Q37353448-874834DA-BC22-4DCD-8108-6FA4EE9F6E70

P304

Q37353448-698371AF-2F3F-41E5-9C72-49DAA7EC1213

P31

Q37353448-2C9156CD-180A-499E-843E-8E036BE7589F

P356

Q37353448-B67EFC82-7014-41FF-B100-D7F5A8358E96

P407

Q37353448-D0CC818B-F775-42FF-96E7-611093F008BD

P433

Q37353448-D0D6D54B-FC14-47A0-9DA0-067CF3557581

P478

Q37353448-C52F9D13-3D1C-4EA6-8AF9-1721272654D3

P50

Q37353448-15D4AB4B-B4CE-4C8D-94F5-2E4ADF72D4E1

Q37353448-A8E890DA-50FF-4C1C-8EFF-A5A6ED544989

P577

Q37353448-064EA5B0-112E-4706-9DC9-0363FB35951D

P698

Q37353448-C83878FB-8FB0-488B-BB38-5EA826385BDA

P932

Q37353448-1D46E6E1-D0CB-4395-A4CA-5804782A218A

P356

P1433

British Journal of Clinical Pharmacology

P1476

Understanding the dose-respons ...... predicting the optimal dosage

@en

P2093

Garry G Graham

http://www.w3.org/2001/XMLSchema#string

Ian Portek

http://www.w3.org/2001/XMLSchema#string

Indira Datta

http://www.w3.org/2001/XMLSchema#string

Kenneth M Williams

http://www.w3.org/2001/XMLSchema#string

Kevin D Pile

http://www.w3.org/2001/XMLSchema#string

Praveen L Indraratna

http://www.w3.org/2001/XMLSchema#string

Sophie L Stocker

http://www.w3.org/2001/XMLSchema#string

P2860

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Relation between adverse events associated with allopurinol and renal function in patients with gout

Prediction of creatinine clearance from serum creatinine

Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.

Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.

Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.

The pharmacokinetics of oxypurinol in people with gout.

P304

932-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12126

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Diluk Kannangara

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23590252

http://www.w3.org/2001/XMLSchema#string

P932

3845316

http://www.w3.org/2001/XMLSchema#string